ZeroBounce Launches Email Warmup Tool to Enhance Email Deliverability and ROI
ZeroBounce Warmup helps sales pros land more emails in the inbox.
SANTA BARBARA, CALIF. / ACCESSWIRE / October 8, 2024 / ZeroBounce today announces its latest product, an email warmup tool helping companies improve deliverability and email marketing ROI. This new addition to ZeroBounce's email validation and deliverability toolkit is especially helpful to sales professionals across all industries.
ZeroBounce Warmup gradually repairs, builds, and maintains a positive sender reputation for new or tarnished email accounts, ensuring that emails can arrive in the inbox rather than landing in spam.
The tool automates the warmup process by emulating existing sending patterns and slowly increasing the number of emails sent. It also simulates authentic, organic engagement by factoring in essential details like current engagement, prior sending habits, time zones, and more. Sales professionals and marketers can thus establish a better reputation with email service providers and land more emails in the inbox.
"Email deliverability is the backbone of any successful email program, and IP warming plays a crucial part in it," said Liviu Tanase, founder and CEO of ZeroBounce. "Our new email warmup tool gives businesses a powerful way to boost their inbox placement and ROI. Paired with our email verifier and deliverability toolkit, ZeroBounce Warmup helps every sender build trust with inbox providers."
ZeroBounce's email warmup tool allows users to customize their email warmup process. Whether a company is launching a new domain, scaling up its email volume, or recovering from deliverability issues, the tool's flexible engagement rules help email performance.
Default: A standard email warmup process gradually increasing interaction volume and ensuring a smooth transition to full-scale email engagements.
Slow Pace: Ideal for new domains or IPs, this rule adopts a cautious approach and increases interaction to build trust with email providers.
Repair: Designed for domains or IPs with deliverability issues, this rule helps restore sender reputation and credibility by focusing on targeted interactions.
Boost: Perfect for established senders, this rule amplifies interaction volume during peak periods to boost engagement metrics.
Protect: For businesses with consistent email performance, this rule maintains a steady pace of interaction for high inbox placement and click rates.
ZeroBounce's email warmup services support sales pros and businesses at every stage of their email marketing journey and help them reach their audience. For more information about ZeroBounce Warmup, visit https://www.zerobounce.net/services/email-warmup.
About ZeroBounce
ZeroBounce is an award-winning email validation, deliverability, and email-finding company that helps businesses improve their email performance. With a focus on accuracy, security, and customer support, ZeroBounce is the go-to choice for more than 350,000 customers worldwide.
ZeroBounce's 99% accurate email validation service helps senders prevent bounces and maintain a good reputation. ZeroBounce's email deliverability toolkit further supports companies in reaching the inbox. Email Finder provides professionals with valid business email addresses to enhance their email outreach efforts, while DMARC Monitor helps organizations enhance domain security.
For more information, visit https://www.zerobounce.net.
Contact Information
Corina Leslie
PR Manager
support@zerobounce.net
+1-888-500-9521
SOURCE: ZeroBounce
View the original press release on newswire.com.
ZeroBounce

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 15:05:00 EET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 14:00:00 EET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 13:00:00 EET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 13:00:00 EET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 19:35:00 EET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom